ASX - By Stock
|
IMU |
Re:
Ann: Half Yearly Report and Accounts
|
|
Sitight
|
143 |
64K |
29 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
143
|
64K
|
29
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Sitight
|
30K |
15M |
33 |
15/03/24 |
15/03/24 |
Charts
|
30K
|
15M
|
33
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Sitight
|
12K |
6.0M |
52 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
12K
|
6.0M
|
52
|
|
ASX - By Stock
|
RCE |
Re:
[INTERVIEW] CEO buys another $300,000 stake in Recce Pharmaceuticals (ASX:RCE)
|
|
Sitight
|
38 |
11K |
0 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
38
|
11K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
[INTERVIEW] CEO buys another $300,000 stake in Recce Pharmaceuticals (ASX:RCE)
|
|
Sitight
|
38 |
11K |
8 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
38
|
11K
|
8
|
|
ASX - By Stock
|
RCE |
Re:
Ann: DFI Clinical Trial Outpatient Nurses Appointed
|
|
Sitight
|
26 |
10K |
3 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
26
|
10K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: DFI Clinical Trial Outpatient Nurses Appointed
|
|
Sitight
|
26 |
10K |
13 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
26
|
10K
|
13
|
|
ASX - By Stock
|
RCE |
Re:
Shorter In The House - ASIC Where Are You?
|
|
Sitight
|
59 |
17K |
13 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
59
|
17K
|
13
|
|
ASX - By Stock
|
RCE |
Re:
Shorter In The House - ASIC Where Are You?
|
|
Sitight
|
59 |
17K |
8 |
05/03/23 |
05/03/23 |
ASX - By Stock
|
59
|
17K
|
8
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Anti-Infective Research Unit est. at Murdoch Children's
|
|
Sitight
|
38 |
15K |
8 |
16/12/22 |
16/12/22 |
ASX - By Stock
|
38
|
15K
|
8
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Sitight
|
48 |
12K |
11 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
48
|
12K
|
11
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Expansion and Acceleration of Clinical Programs
|
|
Sitight
|
70 |
26K |
8 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
70
|
26K
|
8
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Expansion and Acceleration of Clinical Programs
|
|
Sitight
|
70 |
26K |
10 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
70
|
26K
|
10
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Expansion and Acceleration of Clinical Programs
|
|
Sitight
|
70 |
26K |
15 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
70
|
26K
|
15
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Delivers Opening R&D Address at World AMR Congress
|
|
Sitight
|
30 |
11K |
4 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
30
|
11K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Conversion of Performance Shares
|
|
Sitight
|
59 |
22K |
3 |
03/09/22 |
03/09/22 |
ASX - By Stock
|
59
|
22K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Conversion of Performance Shares
|
|
Sitight
|
59 |
22K |
0 |
03/09/22 |
03/09/22 |
ASX - By Stock
|
59
|
22K
|
0
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
6 |
14/08/22 |
14/08/22 |
ASX - By Stock
|
2.1K
|
622K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Dr Philip Sutton - V.P. of Translational Sciences
|
|
Sitight
|
17 |
8.2K |
11 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
17
|
8.2K
|
11
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
5 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
2.1K
|
622K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Dr Philip Sutton - V.P. of Translational Sciences
|
|
Sitight
|
17 |
8.2K |
21 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
17
|
8.2K
|
21
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I Clinical Trial R327 Advances to 4000mg
|
|
Sitight
|
15 |
8.0K |
15 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
15
|
8.0K
|
15
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
7 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
2.1K
|
622K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I Clinical Trial R327 Advances to High Dose Cohort
|
|
Sitight
|
11 |
6.9K |
10 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
11
|
6.9K
|
10
|
|
ASX - By Stock
|
RCE |
Re:
Biotech Roundtable - virtual event in Germany
|
|
Sitight
|
8 |
3.4K |
10 |
10/04/22 |
10/04/22 |
ASX - By Stock
|
8
|
3.4K
|
10
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
7 |
19/02/22 |
19/02/22 |
ASX - By Stock
|
2.1K
|
622K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Safety Data from Third Cohort of PI Clinical Trial
|
|
Sitight
|
37 |
9.7K |
20 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
37
|
9.7K
|
20
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
8 |
22/01/22 |
22/01/22 |
ASX - By Stock
|
2.1K
|
622K
|
8
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
19 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
2.1K
|
622K
|
19
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
10 |
17/01/22 |
17/01/22 |
ASX - By Stock
|
2.1K
|
622K
|
10
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection
|
|
Sitight
|
103 |
28K |
7 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
103
|
28K
|
7
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
7 |
20/12/21 |
20/12/21 |
ASX - By Stock
|
2.1K
|
622K
|
7
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
5 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
2.1K
|
622K
|
5
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
1 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
2.1K
|
622K
|
1
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
5 |
04/09/21 |
04/09/21 |
ASX - By Stock
|
2.1K
|
622K
|
5
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
4 |
04/09/21 |
04/09/21 |
ASX - By Stock
|
2.1K
|
622K
|
4
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
2 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
2.1K
|
622K
|
2
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
4 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
2.1K
|
622K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Appendix 4E
|
|
Sitight
|
35 |
8.1K |
9 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
35
|
8.1K
|
9
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
9 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
2.1K
|
622K
|
9
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
1 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
2.1K
|
622K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Change in substantial holding
|
|
Sitight
|
77 |
23K |
7 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
77
|
23K
|
7
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
5 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
2.1K
|
622K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Anti-Viral Patent Granted in USA for RECCE Anti-Infectives
|
|
Sitight
|
85 |
24K |
12 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
85
|
24K
|
12
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Multiple Patients Dosed in Topical Phase I/II Clinical Trial
|
|
Sitight
|
109 |
28K |
12 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
109
|
28K
|
12
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Multiple Patients Dosed in Topical Phase I/II Clinical Trial
|
|
Sitight
|
109 |
28K |
14 |
18/07/21 |
18/07/21 |
ASX - By Stock
|
109
|
28K
|
14
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Multiple Patients Dosed in Topical Phase I/II Clinical Trial
|
|
Sitight
|
109 |
28K |
8 |
13/07/21 |
13/07/21 |
ASX - By Stock
|
109
|
28K
|
8
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
4 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
2.1K
|
622K
|
4
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
7 |
03/07/21 |
03/07/21 |
ASX - By Stock
|
2.1K
|
622K
|
7
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Sitight
|
2.1K |
622K |
8 |
13/06/21 |
13/06/21 |
ASX - By Stock
|
2.1K
|
622K
|
8
|
|